|
MTMR2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.44720000000176E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.243230E-03 |
| Normal-vs-Stage2 |
1.318660E-03 |
| Normal-vs-Stage3 |
6.02379999999902E-05 |
| Normal-vs-Stage4 |
1.66120000000269E-06 |
| Stage1-vs-Stage2 |
4.633000E-01 |
| Stage1-vs-Stage3 |
5.903900E-02 |
| Stage1-vs-Stage4 |
9.359300E-03 |
| Stage2-vs-Stage3 |
5.110000E-01 |
| Stage2-vs-Stage4 |
1.808440E-01 |
| Stage3-vs-Stage4 |
4.523800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.59299999999263E-05 |
| Normal-vs-AfricanAmerican |
2.547600E-01 |
| Normal-vs-Asian |
2.537200E-03 |
| Caucasian-vs-AfricanAmerican |
1.962190E-01 |
| Caucasian-vs-Asian |
8.732200E-01 |
| AfricanAmerican-vs-Asian |
2.773000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.563680E-04 |
| Normal-vs-Female |
1.167450E-04 |
| Male-vs-Female |
5.252800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.178100E-03 |
| Normal-vs-Age(41-60Yrs) |
3.5410000000069E-05 |
| Normal-vs-Age(61-80Yrs) |
2.955000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.343860E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.204400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.292810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.509600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.333600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.210600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.735600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.350000E-01 |
| Classical-VS-Follicular |
1.626220E-01 |
| Classical-VS-Other |
4.289600E-01 |
| Classical-VS-Normal |
3.879700E-03 |
| Tall-VS-Follicular |
9.078600E-01 |
| Tall-VS-Other |
7.125200E-01 |
| Tall-VS-Normal |
6.457400E-03 |
| Follicular-VS-Other |
7.761600E-01 |
| Follicular-VS-Normal |
9.157500E-04 |
| Other-VS-Normal |
3.394500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.08620000000204E-06 |
| Normal-vs-N1 |
1.041660E-04 |
| N0-vs-N1 |
6.606800E-01 |
|
|
